Your browser doesn't support javascript.
Immunosuppression impaired the immunogenicity of inactivated SARS-CoV-2 vaccine in non-dialysis kidney disease patients.
Zhang, Yue-Miao; Liu, Xing-Zi; Lin, Miao-Miao; Zan, Jin-Can; Hu, Yi-Tong; Wang, Xiang-Qiu; Wu, Wen-Qi; Zhou, Tai-Cheng; Lv, Ji-Cheng; Zhang, Hong; Yang, Li; Zhang, Zi-Jie.
  • Zhang YM; Renal Division, Department of Medicine, Peking University First Hospital, Renal Pathology Center, Institute of Nephrology, Peking University, Key Laboratory of Renal Disease, Ministry of Health of China, Key Laboratory of CKD Prevention and Treatment, Ministry of Education of China; Research Units o
  • Liu XZ; Renal Division, Department of Medicine, Peking University First Hospital, Renal Pathology Center, Institute of Nephrology, Peking University, Key Laboratory of Renal Disease, Ministry of Health of China, Key Laboratory of CKD Prevention and Treatment, Ministry of Education of China; Research Units o
  • Lin MM; Department of Integrated Traditional Chinese and Western Medicine, Peking University First Hospital; Institute of Integrated Traditional Chinese and Western Medicine, Peking University, Beijing 100034, China.
  • Zan JC; Renal Division, Department of Medicine, Peking University First Hospital, Renal Pathology Center, Institute of Nephrology, Peking University, Key Laboratory of Renal Disease, Ministry of Health of China, Key Laboratory of CKD Prevention and Treatment, Ministry of Education of China; Research Units o
  • Hu YT; Peking University Health Science Center, Beijing 100191, China.
  • Wang XQ; Peking University Health Science Center, Beijing 100191, China.
  • Wu WQ; Peking University Health Science Center, Beijing 100191, China.
  • Zhou TC; Center Lab and Liver Disease Research Center, The Affiliated Hospital of Yunnan University, Kunming, Yunnan 650091, China.
  • Lv JC; Renal Division, Department of Medicine, Peking University First Hospital, Renal Pathology Center, Institute of Nephrology, Peking University, Key Laboratory of Renal Disease, Ministry of Health of China, Key Laboratory of CKD Prevention and Treatment, Ministry of Education of China; Research Units o
  • Zhang H; Renal Division, Department of Medicine, Peking University First Hospital, Renal Pathology Center, Institute of Nephrology, Peking University, Key Laboratory of Renal Disease, Ministry of Health of China, Key Laboratory of CKD Prevention and Treatment, Ministry of Education of China; Research Units o
  • Yang L; Renal Division, Department of Medicine, Peking University First Hospital, Renal Pathology Center, Institute of Nephrology, Peking University, Key Laboratory of Renal Disease, Ministry of Health of China, Key Laboratory of CKD Prevention and Treatment, Ministry of Education of China; Research Units o
  • Zhang ZJ; State Key Laboratory for Conservation and Utilization of Bio-resource and School of Life Sciences, Yunnan University, Kunming, Yunnan 650091, China. Electronic address: zijiezhang@ynu.edu.cn.
J Infect ; 85(2): 174-211, 2022 08.
Article in English | MEDLINE | ID: covidwho-1921121
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Immunologic Deficiency Syndromes / Kidney Diseases Topics: Vaccines Limits: Humans Language: English Journal: J Infect Year: 2022 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Immunologic Deficiency Syndromes / Kidney Diseases Topics: Vaccines Limits: Humans Language: English Journal: J Infect Year: 2022 Document Type: Article